Recall due to deviations from the specified values regarding resuspendability

Recall due to exceeding the active ingredient content

Recall due to delivery of an incorrect batch in Austria

Important information from the Federal Office for Safety in Health Care about the known risk of diabetic ketoacidosis (DKA) in cats with diabetes mellitus associated with the use of Senvelgo 15 mg/ml oral solution for cats (velagliflozin).

Recall due to non-compliant manufacture

Important information from the Federal Office for Safety in Health Care concerning the suspension of the marketing authorization and the recall of all batches of the veterinary medicinal product "Kexxtone 32.4 g continuous-release intraruminal device for cattle. Monensin"

Recall due to possible lack of efficacy and unintentional ingestion in non-target species

Recall due to possible non-sterility

Recall due to deviations from the specified values regarding appearance and pH value

With the entry into force of Regulation (EU) 2019/6, medicinal products for certain pet animals, which were previously not subject to a marketing authorization requirement under Section 7(4) of the AMG, may now only be marketed in Germany if they have been notified to the BASG.